rupiya.io
⠋Loading...
0%
❯ Pulling quarterly results...
Sagility Ltd is a Health Information Services company listed on NSE. The page combines exchange quotes, financial statements, shareholding, filings, and news so investors can review the business in one place.
Sagility Ltd makes money through Domestic formulations, Exports and regulated markets, Specialty or institutional sales in Health Information Services. Revenue quality depends on demand growth, margin discipline, balance-sheet strength, and the company's ability to defend its position within Healthcare.
Create a free account to view momentum, moving averages, and delivery signals.
Upgrade to view volatility, drawdown, factor, and risk metrics.
| Period | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|
| Sales | ₹923 Cr | ₹4,218 Cr | ₹4,754 Cr | |
| Expenses | ₹730 Cr | ₹3,179 Cr | ₹3,665 Cr | |
| Operating Profit | ₹193 Cr | ₹1,039 Cr | ₹1,088 Cr | |
| OPM % | 21.0% | 25.0% | 23.0% | |
| Other Income | ₹18 Cr | ₹5 Cr | ₹28 Cr | |
| Depreciation | ₹147 Cr | ₹644 Cr | ₹689 Cr | |
| Interest | ₹65 Cr | ₹215 Cr | ₹185 Cr | |
| Profit Before Tax | ₹-2 Cr | ₹186 Cr | ₹242 Cr | |
| Tax | ₹-2 Cr | ₹186 Cr | ₹242 Cr | |
| Net Profit | ₹-5 Cr | ₹144 Cr | ₹228 Cr | |
| EPS (₹) | -0.0 | 0.8 | 0.5 | |
| Dividend Payout % | 0% | 0% | 0% |
Register free to see 1 more year.
| Quarter | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | ₹1,116 Cr | ₹1,094 Cr | ₹1,260 Cr | ₹1,283 Cr | |||||||
| Expenses | ₹852 Cr | ₹860 Cr | ₹1,000 Cr | ₹976 Cr | |||||||
| Operating Profit | ₹264 Cr | ₹234 Cr | ₹260 Cr | ₹307 Cr | |||||||
| OPM % | 24.0% | 21.0% | 21.0% | 24.0% | |||||||
| Depreciation | ₹166 Cr | ₹171 Cr | ₹176 Cr | ₹176 Cr | |||||||
| Interest | ₹47 Cr | ₹48 Cr | ₹47 Cr | ₹43 Cr | |||||||
| Net Profit | ₹42 Cr | ₹35 Cr | ₹71 Cr | ₹80 Cr | |||||||
| EPS (₹) | 0.2 | 0.2 | 0.4 | 0.2 |
Register free to see 7 more quarters.
| Period | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Liabilities | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Equity Capital | ₹1,919 Cr | ₹1,919 Cr | ₹4,285 Cr | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Reserves | ₹2,108 Cr | ₹4,288 Cr | ₹2,158 Cr | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Borrowings | ₹4,788 Cr | ₹2,896 Cr | ₹2,532 Cr | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Other Liabilities | ₹1,271 Cr | ₹1,427 Cr | ₹1,554 Cr | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Total Liabilities | ₹10,085 Cr | ₹10,529 Cr | ₹10,529 Cr | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Assets | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Fixed Assets | ₹8,621 Cr | ₹8,607 Cr | ₹8,667 Cr | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Investments | ₹0 Cr | ₹0 Cr | ₹0 Cr | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Receivables | — | — | — | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Inventory | — | — | — | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Cash & Equivalents | — | — | — | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Other Assets | ₹1,459 Cr | ₹1,922 Cr | ₹1,856 Cr | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Total Assets | ₹10,085 Cr | ₹10,529 Cr | ₹10,529 Cr | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Register free to see 1 more year.
| Period | Operating | Investing | Financing | Net Cash Flow |
|---|---|---|---|---|
| Mar 2023 | ₹-32 Cr | ₹-7,711 Cr | ₹8,116 Cr | — |
| Mar 2024 | ₹857 Cr | ₹-101 Cr | ₹-545 Cr | — |
| Mar 2025 | ₹973 Cr | ₹-463 Cr | ₹-751 Cr | — |
| Mar 2026 |
Register free to see 1 more year.
No dividend history available.
No corporate actions recorded.
| Company | M.Cap | P/E | ROE | 1Y Return |
|---|---|---|---|---|
| Dr. Agarwals Health Care Ltd | ₹14,010 Cr | 111.6 | 0.00% | -5.14% |
| Fabtech Technologies Ltd | ₹669 Cr | 15.0 | +12.94% | -30.43% |
| Fischer Medical Ventures Ltd | ₹2,284 Cr | 59.2 | 0.00% | -16.13% |
| Inventurus Knowledge Solutions Ltd | ₹26,681 Cr | 37.7 | 0.00% | +18.65% |
| Indegene Ltd | ₹12,256 Cr | 28.0 | +13.94% | -6.98% |
Create a free account to see institutional ownership snapshots.
Create a free account to view recent director and promoter trades.
Create a free account to view recent institutional deal activity.
Create a free account to view analyst estimate summaries.
Create a free account to view ESG risk and governance summaries.
Upgrade to view issuer ratings, instruments, outlooks, and rating history.
rupiya.io is for research and education only. Metrics shown are not investment advice. Validate with SEBI-regulated disclosures before acting.